StockDrifts LogoStockDrifts

Finemedix 387570

Company
파인메딕스Finemedix
Insiders
1
Buys
1
Total Value
₩50M ($35K)
Avg Return
-29.20%
Last Filing
2025-03-21

Finemedix (387570) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩50M ($35K) in reported transaction value. The earliest filing StockDrifts holds for Finemedix is dated 2024-12-26; the most recent is 2025-03-21. Across these filings the average return since disclosure is -29.20%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-03-21BUYMarket Buy
전성우
Seongwoo Jeon
CEO5.0K₩10,070-29.2%₩50M ($35K)
2024-12-26BUY신규상장
전성우
Seongwoo Jeon
CEO1.5M₩16,000-55.4%₩23.8B ($16.6M)
2024-12-26BUY신규상장
황중보
Hwang Jung-bo
moving4.1K₩16,000-55.4%₩66M ($46K)
2024-12-26BUY신규상장
김성철
Seongcheol Kim
vice president177.6K₩16,000-55.4%₩2.8B ($2.0M)

Frequently asked questions

Who has been buying Finemedix stock?
1 distinct insiders have filed 1 disclosed insider purchases in Finemedix (387570), most recently on 2025-03-21. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Finemedix have?
Finemedix has 1 buy-side and 0 sell-side disclosures on record, covering ₩50M ($35K) in total reported value, spanning 2024-12-26 to 2025-03-21.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.